Shetty Mahesh Kalappa, Shah Yogesh P
Department of Radiology, Baylor College of Medicine, The Woman's Hospital of Texas, Houston 77054, USA.
J Ultrasound Med. 2002 Nov;21(11):1211-6; quiz 1217-9. doi: 10.7863/jum.2002.21.11.1211.
To evaluate the value of combined negative sonographic and mammographic findings in patients with palpable breast abnormalities.
One hundred seventy-two patients with 186 palpable abnormalities who had combined negative sonographic and mammographic findings were prospectively studied. Patients who did not undergo biopsy had imaging and clinical follow-up; the mean follow-up period was 28.9 months (range, 24-33 months).
Twelve patients underwent biopsy; benign histologic diagnoses were reported in all 12 (12 [6.9%] of 172). In the remaining 160 patients who were followed, there was no interval development of breast cancer at the site of the palpable abnormality. The negative predictive value of combined negative mammographic and sonographic findings in a patient with a palpable abnormality of the breast was 100%.
Our findings suggest that in a patient with a palpable abnormality of the breast, the negative predictive value of combined normal sonographic and mammographic findings is very high and is therefore reassuring to the patient.
评估超声和乳腺钼靶检查结果均为阴性对可触及乳腺异常患者的价值。
前瞻性研究了172例患者,共186处可触及异常,其超声和乳腺钼靶检查结果均为阴性。未接受活检的患者进行影像学和临床随访;平均随访期为28.9个月(范围24 - 33个月)。
12例患者接受了活检;所有12例(172例中的12例[6.9%])组织学诊断均为良性。在其余接受随访的160例患者中,可触及异常部位未出现乳腺癌进展。乳腺可触及异常患者超声和乳腺钼靶检查结果均为阴性的阴性预测值为100%。
我们的研究结果表明,对于乳腺可触及异常的患者,超声和乳腺钼靶检查结果均正常的阴性预测值非常高,因此可使患者安心。